Guanosine 3',5'-cyclic monophosphate
Guanosine 3',5'-cyclic monophosphate structure
|
Common Name | Guanosine 3',5'-cyclic monophosphate | ||
|---|---|---|---|---|
| CAS Number | 7665-99-8 | Molecular Weight | 345.20500 | |
| Density | 2.64g/cm3 | Boiling Point | 792.7ºC at 760 mmHg | |
| Molecular Formula | C10H12N5O7P | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 433.2ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | 3',5'-cyclic GMP |
|---|---|
| Synonym | More Synonyms |
| Density | 2.64g/cm3 |
|---|---|
| Boiling Point | 792.7ºC at 760 mmHg |
| Molecular Formula | C10H12N5O7P |
| Molecular Weight | 345.20500 |
| Flash Point | 433.2ºC |
| Exact Mass | 345.04700 |
| PSA | 184.62000 |
| Index of Refraction | 2.064 |
| Storage condition | −20°C |
| Water Solubility | 1% sodium bicarbonate: 50 mg/mL |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 22-26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
~%
Guanosine 3',5'... CAS#:7665-99-8 |
| Literature: Synthesis, , # 1 p. 53 - 54 |
|
~%
Guanosine 3',5'... CAS#:7665-99-8 |
| Literature: Journal of Pharmacology and Experimental Therapeutics, , vol. 273, # 1 p. 16 - 25 |
|
~%
Guanosine 3',5'... CAS#:7665-99-8 |
| Literature: Angewandte Chemie - International Edition, , vol. 40, # 6 p. 1046 - 1048 |
|
~%
Guanosine 3',5'... CAS#:7665-99-8 |
| Literature: Angewandte Chemie - International Edition, , vol. 40, # 6 p. 1046 - 1048 |
|
~%
Guanosine 3',5'... CAS#:7665-99-8 |
| Literature: Angewandte Chemie - International Edition, , vol. 40, # 6 p. 1046 - 1048 |
|
~%
Guanosine 3',5'... CAS#:7665-99-8 |
| Literature: Angewandte Chemie - International Edition, , vol. 40, # 6 p. 1046 - 1048 |
![[7-(carboxymethoxy)coumarin-4-yl]methyl ester of cGMP structure](https://www.chemsrc.com/caspic/398/339291-50-8.png)
![[7-(carboxymethoxy)coumarin-4-yl]methyl ester of cGMP structure](https://www.chemsrc.com/caspic/405/339291-45-1.png)
![cyclic guanosine-3',5'-monophosphate [6,7-bis(carboxymethoxy)coumarin-4-yl]methyl ester structure](https://www.chemsrc.com/caspic/312/339291-52-0.png)
![cyclic guanosine-3',5'-monophosphate [6,7-bis(carboxymethoxy)coumarin-4-yl]methyl ester structure](https://www.chemsrc.com/caspic/367/339291-46-2.png)
| Precursor 6 | |
|---|---|
| DownStream 4 | |
CAS#:31356-94-2
CAS#:117-68-0
CAS#:85-32-5|
H89 enhances the sensitivity of cancer cells to glyceryl trinitrate through a purinergic receptor-dependent pathway.
Oncotarget 6(9) , 6877-86, (2015) High doses of the organic nitrate glyceryl trinitrate (GTN), a nitric oxide (NO) donor, are known to trigger apoptosis in human cancer cells. Here, we show that such a cytotoxic effect can be obtained... |
|
|
Atrial natriuretic peptide inhibits cell cycle activity of embryonic cardiac progenitor cells via its NPRA receptor signaling axis.
Am. J. Physiol. Cell Physiol. 308(7) , C557-69, (2015) The biological effects of atrial natriuretic peptide (ANP) are mediated by natriuretic peptide receptors (NPRs), which can either activate guanylyl cyclase (NPRA and NPRB) or inhibit adenylyl cyclase ... |
|
|
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults.
Clin. Exp. Immunol. 182 , 289-301, (2015) VRC-HIVMAB060-00-AB (VRC01) is a broadly neutralizing HIV-1 monoclonal antibody (mAb) isolated from the B cells of an HIV-infected patient. It is directed against the HIV-1 CD4 binding site and is cap... |
| 2-Amino-6-oxo-6,9-dihydro-1H-purine 3-oxide |
| 3',5'-cyclic guanosine monophosphate |
| guanine-3-N-oxide |
| 2-Amino-1,7-dihydro-6H-purin-6-one 3-oxide |
| guanine-N3-oxide |
| MFCD00070129 |
| purine-N-oxide |
| guanosine 3',5'-monophosphate |
| 2-amino-6H-purin-6-one 3-oxide |
| EINECS 231-641-6 |
| Guanin-3-N-oxid |
| 3',5'-cyclic monophosphate of guanosine |
| 2-amino-3-oxy-1,7(9)-dihydro-purin-6-one |
| GUANOSINE 3':5'-CYCLIC MONOPHOSPHATE |
| guanosine 3',5'-cyclic monophosphate |